Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.
about
The role of the immune system in non-small cell lung carcinoma and potential for therapeutic interventionLung Cancer Gene Signatures and Clinical PerspectivesIdentification of stage-specific biomarkers in lung adenocarcinoma based on RNA-seq data.Lepidic and micropapillary growth pattern and expression of Napsin A can stratify patients of stage I lung adenocarcinoma into different prognostic subgroup.An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis.Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancerThyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinomaNaked cuticle Drosophila 1 expression in histologic subtypes of small adenocarcinoma of the lungMicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients.EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients withPathologic heterogeneity of lung adenocarcinomas: A novel pathologic index predicts survival.Pathologic classification of adenocarcinoma of lung.Advances in EGFR as a Predictive Marker in Lung Adenocarcinoma.Prognostic role of TPL2 in early‑stage non‑small cell lung cancer.Development of a database system and image viewer to assist in the correlation of histopathologic features and digital image analysis with clinical and molecular genetic information.Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures.Micropapillary mucinous adenocarcinoma of the lung: a brief case report.INTEGRATIVE ANALYSIS FOR LUNG ADENOCARCINOMA PREDICTS MORPHOLOGICAL FEATURES ASSOCIATED WITH GENETIC VARIATIONS.Small non-coding RNA biomarkers in sputum for lung cancer diagnosis.[Novel morphological and molecular aspects of lung cancer].Toward personalized medicine of lung cancer: response to nontargeted therapy in invasive pulmonary adenocarcinoma as a function of tumor cell differentiation.Prognostic relevance of TTF-1 expression in stage I adenocarcinoma.Sortilin limits EGFR signaling by promoting its internalization in lung cancer.Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer.Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma.Mucinous micropapillary pattern in lung adenocarcinomas: a unique histology with genetic correlates.[Expression and clinical significance of the thyroid transcription factor 1 in Xuanwei lung adenocarcinoma].
P2860
Q27024781-4E523EAE-5169-48F0-987B-009D1CECF18AQ28387769-6D4F342A-33E8-40F1-A9BD-F63DCA60CF20Q30929193-8844B8CC-A3C5-4D8E-84BD-316FACBD8D08Q33582932-AF948ECB-08F1-4444-8C47-016E71C14357Q35920986-AF907429-B5C8-41DE-8E0B-554C942847B5Q35954585-101F203B-63B2-42AB-90E8-11B68948C1E3Q36430129-07B7EB5B-555C-4178-9F0D-D8C327855FD2Q36673780-43F76EF4-0E28-4A7B-B5B9-130DFC1236DBQ36952625-392D82EE-F56D-4D08-9409-3B8682354596Q36952749-FBB01978-7646-44A3-99E8-EC105473FFB6Q36983401-360B5698-BD21-49EA-9CEE-ADA96779A7F6Q37290532-D734E9EC-64DC-485A-A680-AEE86B818B0FQ37472017-6DF73314-34B2-441C-9229-965E3FA0910DQ37626124-2FCA4711-CE58-4556-89FF-936FAE6B6FB8Q37688529-DCFEFD2F-F2F7-4BEB-A165-248814B312DEQ38134347-D007F048-33A2-4FBC-8D72-FC192737408AQ38526025-9885E058-6541-46E0-BAC5-4F297228C6D2Q38732692-EA300DD0-EBCA-4B2D-BBA7-6F32A053C776Q40095964-6B30872E-91F1-4FDB-9C1E-37FA465D2066Q40144219-4909A21D-0B22-4A5C-B78D-96F08F289600Q41281438-677D42EB-FE07-4FB8-A791-E3ED6E8C1E0CQ41863307-3AFEB766-364D-4343-86D8-BDCD1CEAB3C7Q42314942-C73CCC47-4688-406D-9076-87C09CBCE14CQ42789384-1B5890FF-3653-40A2-824A-7481A8A1EC52Q45264604-05E2F9AD-4670-4B4F-A017-9F84E8C94879Q46118162-9FA7D803-93CE-4E82-BA65-65B8C4528BE3Q47110752-E88BB1B9-780C-4A26-9C4B-9C4827377587Q47155647-CA0E6DA2-F76C-438E-BFBF-B53AD15A7DA8Q50321693-4DBC6F9E-47B4-4D2A-8D0F-69E582F7F46DQ53094087-BFBA9783-20CF-40E2-9DA7-F8982CF5ECBCQ53455286-BB06B359-43BB-4C96-8329-7BD1223486BEQ55430486-D55D325C-1682-40B1-8BFB-BA24B0C75865
P2860
Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Histologic patterns and molecu ...... ociated with clinical outcome.
@ast
Histologic patterns and molecu ...... ociated with clinical outcome.
@en
type
label
Histologic patterns and molecu ...... ociated with clinical outcome.
@ast
Histologic patterns and molecu ...... ociated with clinical outcome.
@en
prefLabel
Histologic patterns and molecu ...... ociated with clinical outcome.
@ast
Histologic patterns and molecu ...... ociated with clinical outcome.
@en
P2093
P2860
P356
P1433
P1476
Histologic patterns and molecu ...... ociated with clinical outcome.
@en
P2093
Carmen Behrens
Cesar A Moran
Heather Y Lin
Hector Galindo
Humam Kadara
J Jack Lee
Luisa M Solis
M Gabriela Raso
Neda Kalhor
P2860
P304
P356
10.1002/CNCR.26584
P407
P577
2011-10-21T00:00:00Z